KAREN CHEN: Open Payments
NPI 1164944419 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 33 payments from 9 companies in 2025. Trend: 2023 $226 · 2024 $214 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $304 |
| Merck Sharp & Dohme LLC | 9 | $181 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $165 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
| SERVIER PHARMACEUTICALS LLC | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Incyte Corporation | 1 | $14 |
Products named: CREON, KEYTRUDA, JOURNAVX, ZENPEP, Tibsovo, Nubeqa, WAKIX, Onivyde.
Industry payments across NY — which companies pay providers there.
